The adjustment in price target by a major analyst like Morgan Stanley, while maintaining an Overweight rating, suggests a positive outlook on JPMorgan Chase's fundamentals but with a slightly moderated growth expectation. This could lead to a neutral short-term impact on the stock as the market digests the revised target.